ישראל -
עברית -
Ministry of Health
קוטליק
roche pharmaceuticals (israel) ltd - cobimetinib as hemifumarate - טבליות מצופות פילם - cobimetinib as hemifumarate 20 mg
ישראל -
עברית -
Ministry of Health
מקיניסט 0.5 מג
novartis israel ltd - trametinib as dimethyl sulfoxide - טבליות מצופות פילם - trametinib as dimethyl sulfoxide 0.5 mg - trametinib
ישראל -
עברית -
Ministry of Health
מקיניסט 2 מג
novartis israel ltd - trametinib as dimethyl sulfoxide - טבליות מצופות פילם - trametinib as dimethyl sulfoxide 2 mg - trametinib
ישראל -
עברית -
Ministry of Health
מקטובי 15מג
medison pharma ltd - binimetinib - טבליות מצופות פילם - binimetinib 15 mg - binimetinib
ישראל -
עברית -
Ministry of Health
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
קסאלקורי 250 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
קסאלקורי 250 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
טאגריסו 40 מג
astrazeneca (israel) ltd - osimertinib as mesylate - טבליה - osimertinib as mesylate 40 mg - osimertinib
ישראל -
עברית -
Ministry of Health
טאגריסו 80 מג
astrazeneca (israel) ltd - osimertinib as mesylate - טבליה - osimertinib as mesylate 80 mg - osimertinib